SCHEMBL6792713

SCHEMBL6792713

Cn1ncc2nc3cccc(-c4ccc(N)cc4)c3c(Cl)c21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIT P10721 2/20 0.35
KDR P35968 2/20 0.35
FLT3 P36888 2/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
TP53 P04637 1/20 0.35
GAA P10253 1/20 0.35
PKM P14618 1/20 0.35
ALOX15 P16050 1/20 0.35
HSD17B10 Q99714 1/20 0.35
BPTF Q12830 2/20 0.34
PRMT5 O14744 1/20 0.34
PRKCZ Q05513 1/20 0.34
TUBB4A P04350 7/20 0.33
TUBB P07437 7/20 0.33
TUBA3C P0DPH7 7/20 0.33
TUBA1B P68363 7/20 0.33
TUBA4A P68366 7/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6787706 0.86 TUBB4A (0.47) KDM4EALDH1A1TUBB4ATUBBTUBA3C
SCHEMBL6785181 0.82 ATM (0.43) NPC1RAB9AKDM4EALDH1A1PKM
SCHEMBL6785055 0.80 TUBB4A (0.41) RAB9AKDM4EALDH1A1PRMT5TUBB4A
SCHEMBL6785571 0.76 PDPK1 (0.37) ALDH1A1PRMT5TUBB4ATUBBTUBA3C
SCHEMBL6785261 0.76 TUBB4A (0.38) ALDH1A1PRMT5TUBB4ATUBBTUBA3C
SCHEMBL6786202 0.74 TUBB4A (0.36) KDM4EALDH1A1TP53GAAHSD17B10
SCHEMBL6785029 0.74 ELANE (0.43) KDM4EALDH1A1TP53GAAPKM
SCHEMBL6787760 0.70 MAPT (0.43) KDRKDM4EALDH1A1HSD17B10BPTF
SCHEMBL6784727 0.67 KDR (0.43) KITKDRFLT3BPTFPRMT5
Hydrochloric Acid SCHEMBL6785628 0.66 KDR (0.42) KITKDRFLT3BPTFPRMT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686373-B2 ANALGESICS; ANTIINFLAMMATORY AGENT WARNER-LAMBERT COMPANY LLC 2004-02-03 US disclosed
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors KAWAMURA KIYOSHI (JP) 2003-07-10 US disclosed
EP-1310498-A2 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PFIZER INC. (US) 2003-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PRKCB, PRKCA, PRKCG KIT 1665/4885KDR 3498/4885FLT3 1005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.